US Stock MarketDetailed Quotes
GH Guardant Health
- 18.230
- +0.880+5.07%
Trading Apr 29 11:49 ET
2.22BMarket Cap-4259P/E (TTM)
18.300High17.520Low294.06KVolume17.520Open17.350Pre Close5.30MTurnover0.27%Turnover RatioLossP/E (Static)121.89MShares41.06052wk High14.00P/B2.00BFloat Cap15.81052wk Low--Dividend TTM109.81MShs Float181.070Historical High--Div YieldTTM4.50%Amplitude15.810Historical Low18.035Avg Price1Lot Size
About Guardant Health Company
Guardant Health, Inc. is a precision oncology company engaged in the treatment of cancer through the use of proprietary blood-based tests, vast data sets, and advanced analytics. Its solutions include treatment selection, recurrence detection, and early detection. The company was founded by Helmy Eltoukhy, AmirAli H. Talasaz, and Michael Joseph Wiley in 2011 and is headquartered in Palo Alto, CA.
Company Profile
SymbolGH
Company NameGuardant Health
Listing DateOct 4, 2018
Issue Price19.00
Founded2011
CEOMr. Helmy Eltoukhy
MarketNASDAQ
Employees1779
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address3100 Hanover Street
CityPalo Alto
ProvinceCalifornia
CountryUnited States of America
Zip Code94304
Phone1-855-698-8887
Company Executives
- Name
- Position
- Salary
- Dr. AmirAli Talasaz
- Co-Chief Executive Officer and Director
- 26.42K
- Helmy Eltoukhy
- Co-Chief Executive Officer and Chairman of the Board
- 11.59K
- Darya Chudova
- Chief Technology Officer
- 4.76M
- Kumud Kalia
- Chief Information Officer
- --
- Christopher Freeman
- Chief Commercial Officer
- 3.52M
- Dr. Craig Eagle, M.D.
- Chief Medical Officer
- 3.49M
- Terilyn Juarez Monroe
- Chief People Officer
- --
- Michael Brian Bell
- Chief Financial Officer and Principal Accounting Officer
- 4.12M
- John G. Saia
- Chief Legal Officer and Corporate Secretary
- 3.14M
- Steven E. Krognes
- Independent Director
- 425.21K
- Musa Tariq
- Independent Director
- 725.30K
- Vijaya Gadde
- Independent Director
- 425.21K
- Myrtle S. Potter
- Independent Director
- 425.21K
- Meghan V. Joyce
- Independent Director
- 425.21K
- Ian T. Clark
- Lead Independent Director
- 470.21K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg